Evidence map›Paper›PMID 36685609›Full record

ArticleAmerican journal of medicine open2023

Epidemiological and clinical perspectives of long COVID syndrome.

Katherine Huerne, Kristian B Filion, Roland Grad, Pierre Ernst, Andrea S Gershon, Mark J Eisenberg

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in American journal of medicine open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06294756 (Effects of Sulfurous Thermal Waters Inhalations on Long-COVID Syndrome), which is not on this map. Cited by 52 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 2 pooled it
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06294756 nacompletednot on this map

Effects of Sulfurous Thermal Waters Inhalations on Long-COVID Syndrome: a Double-blinded, Interventional, Randomized Case-control, Pilot Study on a Spa Centered Rehab Program

TypeinterventionalSponsorUniversity of Roma La SapienzaRan2023 to 2023Enrolled30ConditionsLong-COVID, Post COVID-19 Condition, Chronic COVID-19 Syndrome, Post Acute Sequelae of COVID-19ArmsInhalation of Sulfurous Thermal Water, Inhalation of Sterile Distilled non-pyrogenic Water
3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 2 syntheses or guidelines pooled it, 87 citations in OpenAlex.

  1. Effect of interventions for the management of sleep disturbances in patients with long COVID: a systematic review and meta-analysis of randomized controlled trials.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Pooled it
  2. Intervention modalities for brain fog caused by long-COVID: systematic review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Bridging Gaps in Long COVID Therapy: A Review.Current medicinal chemistry · 2026
    Review
  10. Article
  11. Article
  12. Autonomic dysfunction and quality of life in a cohort of neurology outpatients with post-acute sequelae of COVID-19, a two-year follow-up study.Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2026
    Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Artificial Intelligence in Cardiovascular Health: Insights into Post-COVID Public Health Challenges.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Katherine HuerneLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Kristian B FilionLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Roland GradLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Pierre ErnstLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Andrea S GershonSunnybrook Health Sciences Centre and Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Mark J EisenbergLady Davis Institute for Medical Research, Jewish General Hospital, Montreal, QC, Canada.
Jewish General Hospital · CAMcGill University · CAMcGill University Health Centre · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long COVID, or post-acute COVID-19 syndrome, is characterized by multi-organ symptoms lasting 2+ months after initial COVID-19 virus infection. This review presents the current state of evidence for long COVID syndrome, including the global public health context, incidence, prevalence, cardiopulmonary sequelae, physical and mental symptoms, recovery time, prognosis, risk factors, rehospitalization rates, and the impact of vaccination on long COVID outcomes. Results are presented by clinically relevant subgroups. Overall, 10-35% of COVID survivors develop long COVID, with common symptoms including fatigue, dyspnea, chest pain, cough, depression, anxiety, post-traumatic stress disorder, memory loss, and difficulty concentrating. Delineating these issues will be crucial to inform appropriate post-pandemic health policy and protect the health of COVID-19 survivors, including potentially vulnerable or underrepresented groups. Directed to policymakers, health practitioners, and the general public, we provide recommendations and suggest avenues for future research with the larger goal of reducing harms associated with long COVID syndrome.

Indexed as

CardiovascularCOVID-19Long COVID syndromePost-acuteRespiratory

Identifiers

PMID36685609
PMCPMC9846887
OpenAlexW4317780570

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.